The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays (Q42859721)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 August 2007

Language	Label	Description	Also known as
English	The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays	scientific article published on 25 August 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays (English)

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

Christian H. Ottensmeier

6

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

Hendrik Veelken

18

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

Krzysztof Giannopoulos

16

object named as

K Giannopoulos

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

author name string

C M Britten

1

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

C Gouttefangeas

2

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

M J P Welters

3

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

G Pawelec

4

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

S Koch

5

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

A Mander

7

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

S Walter

8

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

A Paschen

9

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

J Müller-Berghaus

10

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

I Haas

11

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

A Mackensen

12

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

T Køllgaard

13

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

P thor Straten

14

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

M Schmitt

15

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

R Maier

17

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

C Bertinetti

19

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

A Konur

20

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

C Huber

21

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

S Stevanović

22

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

T Wölfel

23

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

S H van der Burg

24

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

25 August 2007

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

57

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

3

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

289-302

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Immune monitoring of T-cell responses in cancer vaccine development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Human T cell responses against melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Measurement of cytokine release at the single cell level using the ELISPOT assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Ultrasensitive detection and phenotyping of CD4+ T cells with optimized HLA class II tetramer staining

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Standardization of cytokine flow cytometry assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Targeted therapy for colorectal cancer: mapping the way.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Use of standard criteria for assessment of cancer vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

The immunobiology of cancer immunosurveillance and immunoediting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Ex vivo analysis of human antigen-specific CD8+ T-cell responses: quality assessment of fluorescent HLA-A2 multimer and interferon-gamma ELISPOT assays for patient immune monitoring.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Design and evaluation of antigen-specific vaccination strategies against cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

27 May 2018

Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

16 August 2018

A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

16 August 2018

LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8(+) T-cells by flow cytometry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

16 August 2018

Dextramers: new generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

16 August 2018

Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

16 August 2018

Direct access to CD4+ T cells specific for defined antigens according to CD154 expression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

16 August 2018

Detection of human papillomavirus (HPV) 16-specific CD4+ T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

16 August 2018

Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

16 August 2018

Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150627

16 August 2018

HPV and cervical cancer: screening or vaccination?

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Stability over time of serum antibody levels to human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Effectiveness of preventive human papillomavirus vaccination

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Predictors of HPV vaccine acceptability: a theory-informed, systematic review

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Role of herd immunity in determining the effect of vaccines against sexually transmitted disease

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

New immunization initiatives and progress toward the global control of hepatitis B.

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Vaccination against colonizing bacteria with multiple serotypes

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

The cervical cancer epidemic that screening has prevented in the UK.

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Public health paradoxes and the epidemiological impact of an HPV vaccine

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

1 reference

https://api.crossref.org/works/10.2217%2F14750708.5.3.289

21 January 2018

Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of Elispot assays: influence of method and operator on variability of results

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enumeration of antigen-specific CD8+ T lymphocytes by single-platform, HLA tetramer-based flow cytometry: a European multicenter evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of intracellular cytokines by flow cytometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer vaccines: pessimism in check

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardization and validation issues of the ELISPOT assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flow cytometry controls, instrument setup, and the determination of positivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17721783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2217/14750708.5.3.289

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42859721&oldid=2214192310"